ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial.

Cheol Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.